Karen L Madsen
Karen L Madsen, PhD is an expert in Gastroenterology at University of Alberta (Canada). As of October 2026, ScienceLeadR ranks Karen L Madsen in the top 1% of experts worldwide for Gastroenteritis and Inflammatory Bowel Diseases. Karen L Madsen has authored 242 publications, the most recent in 2026, and is an investigator in 20 clinical trials, 1 of them ongoing. SLR score: 1,097 (community average: 125). How the SLR is computed.
LeadR Profile
Gastroenterology
Subspecialties: Nutrition - Hepatology - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1986 - 2026
Number : 242
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Host-microbe Interactions in the Appendix of Children with Inflammatory Bowel Diseases. PMID 42531280 — crohn disease, appendix, inflammatory bowel diseases, host microbial interactions, digestive system physiological phenomena, child | Am J Physiol Gastrointest Liver Physiol | 2026 | 0 |
| Mast cell-derived IL-13 as a driver of Crohn disease-associated intestinal fibrosis. PMID 42418669 — cells, interleukin-13, vimentin, muscles, crohn disease, fibrosis, pathology, collagen, inositol, inflammatory bowel diseases, tissues, colitis, ulcerative, mast cells, interleukin-4 | Inflamm Bowel Dis | 2026 | 0 |
| The Gut Microbiome in Surgical Oncology: Mechanisms, Perioperative Outcomes, and Therapeutic Opportunities. PMID 42370841 — surgical oncology, melanoma, neoplasms, pneumonia, therapeutics, gastrointestinal microbiome | Br J Surg | 2026 | 0 |
| β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk Cohort. PMID 42214560 — glucans, crohn disease, multiple chronic conditions, inulin, dietary fiber, gastrointestinal microbiome | Gastroenterology | 2026 | 0 |
| IL23R genetic variants associate with Crohn's disease risk and microbiome changes in healthy first-degree relatives. PMID 42208782 — interleukin-23, genes, crohn disease, polymorphism, single nucleotide | Clin Gastroenterol Hepatol | 2026 | 0 |
Clinical Studies 20
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 11
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance NCT04578652 — insulin resistance, insulin, pediatric obesity, gingiva, tablets, adolescent, obesity, therapeutics, dietary fiber, gum arabic, gastrointestinal microbiome, obesity, morbid, metformin | Phase 3 | Recruiting | 2021 |
LeadR Networks
Main global connection map